Single Center Study of Prescribing and Treatment Outcomes of Patients with Chronic Myeloid Leukemia

Single Center Study of Prescribing and Treatment Outcomes of Patients with Chronic Myeloid Leukemia

Background: The present study investigated the patients with Chronic Myeloid Leukemia in chronic phase (CP-CML) who had beenon the first- line Imatinib Mesylate (IM) therapy for a period of 84 months. Materials and Methods: This retrospective study was conducted in 295 newly-diagnosed CP-CML patient...

Full description

Bibliographic Details
Main Authors: Ladan Nekoohesh, Mohammad H. Ghahremani, Shahrbanoo Rostami, Mohsen Nikbakht, Leila Nekoohesh, Roozbeh Naemi, Saeed Mohammadi, Laya Ghadyaninejad, Seyed Asadollah Mousavi, Mohammad Vaezi, Kamran Alimoghaddam, Bahram Chahardouli
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-01-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Chronic myeloid leukemia; Imatinib; Resistance
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1244

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1244

Similar Items